@DefiniensLife

Better biomarker signatures change patient lives. #TissuePhenomics: unique tissue signatures that accelerate cancer breakthroughs.

 Munich, Germany
definiens.com
Joined December 2009
  • Tweets2.4K
  • Following817
  • Followers773
1.1KMedia
During #SITC2019's Workshop on Intratumoral Immunomodulation, the current status of intratumoral immunomodulation will be presented and future directions for the field will be discussed, along with implications for immunotherapy treatments. sitcancer.org/2019/program/p…
3
4
Congratulations @DendreonNews! Largest Real Word Evidence Suggest 4 year #Survival Benefit in #ProstateCancer With #PROVENGE @ThePCRC @PCFnews @ZEROCancer #CRPC #mCRPC #PCSM #immunotherapy #GUcancer #sipleucel theoncoforum.com/largest-rea…
1
2
When Dana-Farber’s Catherine Wu, MD, was a newly minted physician in the mid-1990s, there was just one major form of #immunotherapy for cancer — and it had been designed with an entirely different purpose in mind. ms.spr.ly/6014TOIs8
5
1
20
Thanks @Labiotech_eu for sharing new #research on #cancer #immunotherapy! Off-the-Shelf #Kidney Cancer Immunotherapy More Than Doubles Recovery in Phase II #bioxcell #Bio_X_Cell #invivo #invivoantibodies #invivoantibody labiotech.eu/medical/immunic…
1
1
Results from the phase 2 CheckMate 436 trial demonstrate the potential of nivolumab & brentuximab vedotin combination #immunotherapy for relapsed or refractory primary mediastinal B-cell lymphoma. Read about this promising option: bit.ly/2lV3pEU @JCO_ASCO #ImmunoOnc

Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large...

PURPOSE Primary mediastinal B-cell lymphoma (PMBL) is a rare but aggressive non-Hodgkin lymphoma with poor outcomes in patients with relapsed/refractory (R/R) disease. PMBL is characterized by high...

ascopubs.org
1
1
#IMV Announces Research Collaboration with The #WistarInstitute to Develop New Targeted #Immunotherapy Against the Common #BRAFCancerMutation $IMV 1stoncology.com/blog/imv-ann…
1
1
It is not commonly known that the type of blood cancer a person has can change as the cancer develops. Blood cancer can be very complex and our scientists are dedicated to advancing the science behind it. #BloodCancerAwarenessMonth
3
10
“CAR T-cell therapy is very unique and different from any other treatment we’ve had,” says our @WWierda. Watch to learn how. #endcancer

CAR T-cell therapy for cancer treatment: How it works

Watch Dr. William Wierda discuss how CAR T-cell therapy works in treating children and young adults with acute lymphoblastic leukemia and adults with large B-cell non-Hodgkin’s lymphoma.

7
55
7
148
Join @sloan_kettering's Dana Pe'er, @ICR_London's @bissanao and @Cambridge_Uni's Mihaela van der Scheer to discuss just how big data and AI can accelerate cancer research at our Joint Conference on Engineering and Physical Sciences in Oncology with @AACR: cancerresearchuk.org/funding…
7
1
12
On Labor Day, we celebrate the contributions our team members make toward the strength, prosperity, and well-being of all we serve in the fight against cancer. bit.ly/2ZHInYw
1
12
Latest edition of ESMO Perspectives magazine.esmo.org/edition-8-… @myESMO @grikamartinelli @TaberneroJosep @peters_solange @AndresC27622123
10
18
Definiens retweeted
Ultivue@Ultivue29 Aug 2019
Check out this 40x image of this NSCLC tissue stained with our UltiMapper I/O T-act Kit and scanned with @RareCyte's CyteFinder II. hubs.ly/H0kgD1r0 #tissueimaging #multiplexing #immunooncology #biomarkers #ki67 #tumormicroenvironment
2
2
Check out a 40x image of this NSCLC tissue stained with the UltiMapper I/O T-act Kit from @Ultivue on CyteFinder II. rarecyte.com/cytefinderii/ #tissueimaging #multiplexing #immunooncology #biomarkers #ki67 #tumormicroenvironment
1
1
.@ImmunologyUoB @unibirmingham researchers have found an exciting development in cancer treatments that suggest a way to break tumour’s protective barrier making #immunotherapy more effective birmingham.ac.uk/university/…
2
4
Exciting #cancerimmunology development - researchers at @unibirmingham may have found a way to make #immunotherapies more effective by breaking down the protective barrier surrounding tumours birmingham.ac.uk/news/latest…
13
2
23
Researchers find a weak spot in cancer cells news-medical.net/news/201908… #Cell #Gene #ImmuneSystem #Immunotherapy #Leukemia #Protein #Ubiquitin @elife
2
2
Paper in @NatureCellBio: Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. go.nature.com/2Zys18G __________ #immunotherapy #breastcancer #RNAseq #AcademicTwitter
7
21
New #JITC Short Report: Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events jitc.biomedcentral.com/artic…
2
Dave Fredrickson, Executive Vice President, Oncology, shares our commitment to improving patient outcomes in #ovariancancer.
1
10
This multicenter trial sponsored by the Cancer Immunotherapy Trials Network showed that #FDA-approved #IFNγ can drive #inflammation of #ColdTumors. bit.ly/2Htzbkm
1
1
Load more